Abstract:Objective To explore the association of peripheral brain-derived neurotrophic factor (BDNF) gene expression and serum protein levels with bipolar disorder (BPD).Methods The real-time quantitative reverse transcriptase polymerase chain reaction (RT-qPCR) with TaqMan MGB was used to analyze the BDNF gene mRNA expression in peripheral leukocytes of 61 patients with BPD[32 cases with bipolar mania(BM),29 with bipolar depression(BD)] and 61 healthy controls.The serum BDNF level was measured with enzyme-linked immunosorbent assay (ELISA) method.The symptoms of the patients were assessed with the Hamilton Depression Rating Scale-17 (HAMD17) and Young Mania Rating Scale (YMRS).Results (1) The BDNF gene mRNA expression level in BPD group (0.0077±0.0019) was significantly lower than that in control group (0.0096±0.0028) (t=-3.74,P＜0.01).There was significant difference among three groups on BDNF expression (BM:0.0081±0.0023,BD:0.0073±0.0024 ; F=7.55,P＜0.01).Furthermore,BDNF gene mRNA decreased both in BM and BD group compared with that in controls (P＜0.05,P＜0.01,respectively).However,no difference was found between BM and BD groups (P＞0.05).(2) BDNF serum levels in BPD group (2.80±0.19) was lower than that in control group (2.99±0.49) (t =-2.90,P＜0.01).There was significant difference among three groups on BDNF expression (BM:2.81±0.17,BD:2.79 ±0.21; F=4.21,P＜0.05).Furthermore,BDNF serum levels decreased in both BM and BD compared with those in controls (all P＜0.05,respectively).However no difference was found between BM and BD (P＞0.05).(3) Neither the expression levels nor serum levels of BDNF in BM were correlated with YMRS (P＞0.05),and the same result was found in BD group (P＞0.05).Conclusions The findings suggest that the decreased BDNF levels may be involved in the pathophysiology of BPD,while BDNF levels might not have polarized changes in different status of episodes.

Brain-derived neurotrophic factor gene mRNA and protein expression in patients with bipolar disorder